Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines ( vol 385 , pg 320 , 2021)

被引：0
|
作者：
Thompson, Mark G.
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 390卷 / 08期
关键词：
D O I：
10.1056/NEJMx210021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines (N Engl J Med 2021;385:320-329). In the "Attenuation of Viral RNA Load with Vaccination" subsection of Results (page 325), the second sentence should have read, "The mean viral RNA load was 3.8 log(10) copies per microliter among unvaccinated participants and 2.3 log(10) copies per microliter" rather than "... 3.8 log(10) copies per milliliter ... and 2.3 log(10) copies per milliliter." In Table 3 (page 327), the unit for the mean viral RNA load should have been log(10) copies/mu l rather than log(10) copies/ml. The article is correct at NEJM.org. . . .
引用
收藏
页码：772 / 772
页数：1
相关论文
共 50 条
  • [21] BNT162b2, mRNA-1273, and Sputnik V Vaccines Induce Comparable Immune Responses on a Par With Severe Course of COVID-19
    Kaznadzey, Anna
    Tutukina, Maria
    Bessonova, Tatiana
    Kireeva, Maria
    Mazo, Ilya
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [22] Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans
    Dickerman, Barbra A.
    Madenci, Arin L.
    Gerlovin, Hanna
    Kurgansky, Katherine E.
    Wise, Jessica K.
    Figueroa Muniz, Michael J.
    Ferolito, Brian R.
    Gagnon, David R.
    Gaziano, J. Michael
    Cho, Kelly
    Casas, Juan P.
    Hernan, Miguel A.
    JAMA INTERNAL MEDICINE, 2022, 182 (07) : 739 - 746
  • [23] Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients with Systemic Autoimmune Rheumatic Diseases
    Cook, Claire
    Patel, Naomi
    Fu, Xiaoqing
    Wang, Xiaosong
    Kawano, Yumeko
    Vanni, Kathleen
    Qian, Grace
    Banasiak, Emily
    Kowalski, Emily
    Choi, Hyon
    Zhang, Yuqing
    Sparks, Jeffrey
    Wallace, Zachary
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2368 - 2370
  • [24] Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine (vol 60, pg 891, 2021)
    Lopez-Valle, A.
    Falkenhain-Lopez, D.
    Ruiz-Arranz, C.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (08) : 1101 - 1101
  • [25] Cutaneous reactions due to Pfizer's BNT162b2 mRNA and Moderna's mRNA-1273 vaccines
    Oulee, A.
    Salem, S.
    Yahia, R.
    Yang, K.
    Garcia, D.
    Holmes, A.
    Furukawa, B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (05) : E332 - E334
  • [26] BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis Patients (Vol 19, pg 85, 2024)
    Yau, K.
    Tam, P.
    Chan, C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (12): : 1671 - 1672
  • [27] Effectiveness of BNT162b2 and mRNA-1273 Vaccines against COVID-19 Infection: A Meta-Analysis of Test-Negative Design Studies
    Chang, Shuailei
    Liu, Hongbo
    Wu, Jian
    Xiao, Wenwei
    Chen, Sijia
    Qiu, Shaofu
    Duan, Guangcai
    Song, Hongbin
    Zhang, Rongguang
    VACCINES, 2022, 10 (03)
  • [28] Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries
    Berild, Jacob Dag
    Larsen, Vilde Bergstad
    Thiesson, Emilia Myrup
    Lehtonen, Toni
    Grosland, Mari
    Helgeland, Jon
    Wolhlfahrt, Jan
    Hansen, Jorgen Vinslov
    Palmu, Arto A.
    Hviid, Anders
    JAMA NETWORK OPEN, 2022, 5 (06) : E2217375
  • [29] Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients
    Rodriguez-Espinosa, Diana
    Broseta, Jose Jesus
    Bedini, Jose Luis
    Rodriguez, Nestor
    Maduell, Francisco
    CLINICAL KIDNEY JOURNAL, 2022, 15 (04) : 818 - 819
  • [30] Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Maruoka, Hayato
    Nasu, Seiko
    Nishioka, Tomomi
    Sakizono, Kenji
    Mitsuyuki, Satoshi
    Kubo, Tomoyo
    Okada, Naoki
    Nakagawa, Daishi
    Kamijo, Kimimori
    Imoto, Hiroharu
    Yamamoto, Ryusuke
    Nagai, Yuya
    Hiramoto, Nobuhiro
    Yoshioka, Satoshi
    Yonetani, Noboru
    Matsushita, Akiko
    Miyakoshi, Chisato
    Doi, Asako
    Ishikawa, Takayuki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (03) : 274 - 280
12345